# Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

> **NCT00813592** · PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 2 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** SOM230B

## Key facts

- **NCT ID:** NCT00813592
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Original PI left and company withdrew support.
- **Last updated:** 2014-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813592, "Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00813592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*